MbrlCatalogueTitleDetail

Do you wish to reserve the book?
Molecular characterization of early-stage lung adenocarcinoma presenting as subsolid nodules in a real-life European cohort
Molecular characterization of early-stage lung adenocarcinoma presenting as subsolid nodules in a real-life European cohort
Hey, we have placed the reservation for you!
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Molecular characterization of early-stage lung adenocarcinoma presenting as subsolid nodules in a real-life European cohort
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Title added to your shelf!
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Molecular characterization of early-stage lung adenocarcinoma presenting as subsolid nodules in a real-life European cohort
Molecular characterization of early-stage lung adenocarcinoma presenting as subsolid nodules in a real-life European cohort

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
How would you like to get it?
We have requested the book for you! Sorry the robot delivery is not available at the moment
We have requested the book for you!
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Molecular characterization of early-stage lung adenocarcinoma presenting as subsolid nodules in a real-life European cohort
Molecular characterization of early-stage lung adenocarcinoma presenting as subsolid nodules in a real-life European cohort
Journal Article

Molecular characterization of early-stage lung adenocarcinoma presenting as subsolid nodules in a real-life European cohort

2025
Request Book From Autostore and Choose the Collection Method
Overview
Objectives Subsolid nodules emerged as frequent radiological variants of lung adenocarcinoma. Radiological features including solid-component prevalence and larger tumour dimensions prompt tumoral invasiveness guiding prognosis and management. Thus, we aimed to clarify the molecular grounds that dictate these radiological appearances and clinical behaviour in a real-life European-cohort. Additionally, following the growing interest toward targeted-therapies in early-stage diseases, we aimed to present real-life epidemiological data of actionable mutations in these patients. Methods In this retrospective single-centre study, targeted next-generation sequencing was performed continuatively in all the resected subsolid lung adenocarcinomas in the period between May 2016 and December 2023. Clinico-radiological data were collected. The genetic landscape of our real-life European subsolid adenocarcinoma population is defined. Common and actionable mutations (frequency > 5%) relation to key clinico-radiological features are evaluated. Results Overall, 156 subsolid adenocarcinomas were analysed. KRAS -mutations, mostly KRAS p.G12C , were the most prevalent followed by EGFR , including 25% uncommon EGFR -mutations, TP53 and MET mutations. Amongst the clinico-radiological variables, KRAS -mutations and KRAS p.G12C -mutation were associated to smoking history (≥ 20 pack/years), aggressive histologic subtype and higher consolidation-to-tumor ratio (CTR). Moreover, KRAS -mutated nodules had faster tumour-doubling-time. Conversely, EGFR -mutations were associated to female sex and lower CTR. The latter not being confirmed in common EGFR -mutations. Additionally, in common EGFR -mutated nodules, aggressive histological components were rarer. Conclusion Our study presents the molecular profile of subsolid lung adenocarcinoma in a real-life European-cohort. KRAS -mutations were the most prevalent, and were related to smoking history, higher CTR and faster growth. Conversely, common EGFR -mutations were rarer than expected and unrelated to smoking history and radiological features.